Pharmaceutical Technology on MSN
PRISM BioLab partners with Receptor.AI for molecule discovery
The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.
Vietnam Investment Review on MSN
PRISM BioLab and Receptor AI partner on drug discovery
TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results